Overview
Lock Pharma is a distributor of innovative products for central venous access in the fields of renal therapy, hematology, and oncology. They offer products such as Citra-Lock™ syringe ampoules for securing central catheters, Citra-Valve™ needleless connectors for hemodialysis, and Citra-XS™ biocompatible catheters designed for blood flow. Additionally, they provide WoundClot, a sterile, bioabsorbable dressing for managing moderate to severe arterial and venous bleeding.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2014-01-22. Active
12 1090 1014 0000 0001 2251 5373- 06 1090 1014 0000 0001 2251 5384
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
48 tenders recorded as contractor: 8 national ($253,707) and 40 EU ($16,807,053).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 17, 2026 | Dostawa sprzętu jednorazowego użytku i drobnego sprzętu laboratoryjnego do SPZOZ w Łukowie | — | Samodzielny Publiczny Zakład Opieki Zdrowotnej w Łukowie | |
| Sep 10, 2026 | Dostawa produktów leczniczych, leków do programów lekowych i chemioterapii, środków kontrastowych oraz produktów farmaceutycznych dla USK-1 w Szczecinie | — | Uniwersytecki Szpital Kliniczny Nr 1 Im. Prof. Tadeusza Sokołowskiego Pum w Szczecinie | |
| Sep 9, 2026 | Dostawy Produktów farmaceutycznych | — | Samodzielny Publiczny Zakład Opieki Zdrowotnej w Mogilnie |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the President of the Management Board is authorised independently to effectively submit declarations concerning the company’s proprietary and non-proprietary rights and obligations and to sign agreements on behalf of the company. If the value of the rights or liabilities exceeds PLN 100,000 (one hundred thousand złoty), the consent of the partners’ meeting is required. In the case of a multi-member management board, joint action by at least two members of the management board or by a member of the management board and a commercial proxy (joint representation) is required to effectively submit declarations concerning the company’s proprietary and non-proprietary rights and obligations and to sign agreements on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bartosz Stebnicki (51) | 20,102 | $271,501.89 | 99.5149% |
Others | 98 | $1,323.61 | 0.4851% |
Beneficial owners
| Person | Rights |
|---|---|
Bartosz Stebnicki (51)  | Shareholder of a limited liability company, 1005100.0 PLN |
Subsidiaries
| Name | Share value | Stake | |
|---|---|---|---|
ACME Partnerssp. z o.o. | 45,380.88 USD | 80% |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Vente Amicalesp. z o.o. | $1,850,028.63 | venteamicale.pl | |
| Genoplast BiotechS.A. | $1,843,484.74 | genoplast.pl | |
| Novicaresp. z o.o. | $1,512,398.66 | novicare.pl | |
| Optimed Pro-Office Cirrosp. j. | $1,276,876.90 | cirro.pl | |
| Surgical Solutionssp. z o.o. | $947,852.75 | surgical-solutions.pl | |
| BL Medicasp. z o.o. + limited partnership | $886,794.58 | blmedica.pl | |
| Novisc Pharmasp. z o.o. | $806,018.56 | novisc.com | |
| Model MedicalS.A. | $754,014.76 | modelmedical.pl | |
| Kunctradesp. z o.o. | $720,968.35 | kunctrade.com | |
| Support-Pharmasp. z o.o. | $521,132.71 | support-pharma.pl |
Change history
| Date | Event |
|---|---|
| 2018-11-28 | Share capital change (10,000.00 PLN → 1,010,000.00 PLN) |
| 2018-11-28 | PKD change (Added: 46.62.Z) |
| 2016-02-19 | Name change ("lock Pharma" → Lock Pharma) |
| 2016-02-19 | PKD change (Removed: 20.42.Z, 46.51.Z, 52.10) |
| 2015-12-28 | PKD change (Removed: 18.20.Z, 20.53.Z, 26.51.Z, 26.60.Z, 26.70.Z, 46.18.Z, 46.19.Z, 46.45.Z, 46.52.Z, 46.75.Z, 46.90.Z, 47.19.Z, 47.29.Z, 47.41.Z, 47.99.Z, 58.29.Z, 62.01.Z, 62.02.Z, 62.03.Z, 62.09.Z, 70.10.Z, 70.21.Z, 71.20.A, 71.20.B, 72.11.Z, 72.19.Z, 73.20.Z, 74.10.Z, 74.20.Z, 74.30.Z, 74.90.Z, 77.40.Z, 78.30.Z, 85.60.Z, 86.90.E, 96.09.Z) |
FAQ
Last updated: 2026-07-15